{"title":"Stryker vs Zimmer Biomet: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/stryker-vs-zimmer-biomet","comparison":"Stryker ranks 29 on the Robotics 100 with a score of 86; Zimmer Biomet ranks 60 with 81. Stryker is ahead on positioning and leverage. Level on deployment, production, commercials, progress, technology and firepower. Stryker is based in Portage, United States, Zimmer Biomet in Warsaw, United States. Stryker: Established. Zimmer Biomet: Public. Stryker is named in 10 signals and Zimmer Biomet in 11.","companies":[{"name":"Stryker","url":"https://www.frontiertechintelligence.com/companies/stryker","city":"Portage","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Stryker's Mako surgical-robotics franchise (within the ortho segment of Nasdaq:SYK) has 3,000+ systems installed and 2.5M procedures across 47 countries, with more than two-thirds of US Stryker knee procedures now robotic. It moved the handheld Mako RPS from limited release (February 2026) to full US launch (July 2026) with an ambulatory-surgery-center push, alongside Mako 4 multi-specialty and a shoulder application. Mako-specific figures are group-scoped and not separately disclosed.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":29,"score":86,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":8,"position":10,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Stryker sells Mako SmartRobotics and handheld robotic systems that assist surgeons in joint replacement and other orthopaedic procedures.","segment":"Medical & surgical","layer":"Systems"},"signals_total":10,"facts_total":69},{"name":"Zimmer Biomet","url":"https://www.frontiertechintelligence.com/companies/zimmer-biomet","city":"Warsaw","country":"United States","stage":"Public","founded":null,"last_round":null,"positioning":"Zimmer Biomet is a US orthopedics company (NYSE:ZBH) whose ROSA robotic platform serves knee, hip, and shoulder procedures, now adding the Monogram semi-autonomous TKA system (FDA 510(k) in March 2025, an early-2027 launch) with a fully autonomous version in clinical study since July 2025. It completed the Monogram Technologies acquisition in October 2025. ROSA-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":60,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Zimmer Biomet develops and sells ROSA robotic surgical systems for orthopedic procedures, including robotic assistance and navigation for knee, hip, and brain surgery.","segment":"Medical & surgical","layer":"Systems"},"signals_total":11,"facts_total":4}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}